/ /

Jill Sederstrom
Jill Sederstrom is a Contributing Editor
The Winners and Losers of 340B Changes
The Winners and Losers of 340B Changes
What CMS' big changes to the 340B Drug Discount Program will mean.
Bovine Insulin Is Being Discontinued
Patients will soon have one less option when selecting insulin.
New Research Suggests the Immune System Could Aid In Regulating Insulin in Type 2 Diabetes
The immune system could play a beneficial role in regulating insulin, according to a study from Switzerland.
Medicaid Expansions Mean New Roles for Pharmacists
Medicaid Expansions Mean New Roles for Pharmacists
Pharmacists will be the most frequent point of contact for new Medicaid patients.
Adult Patients Could Be Misdiagnosed with Wrong Form of Diabetes
Type 1 diabetes can present in adults, which can lead to misdiagnosis and unsuccessful treatment.
Integrating Pharmacists into Medical Homes Significantly Improves Outcomes
Having a clinical pharmacist integrated into a medical home benefits diabetes and hypertension patients.
Data Shows Nonmedical Vaccine Exemption Rates Stabilizing
Nonmedical exemption rates for childhood vaccinations appear to have hit a plateau.
Majority of Adults Are Unaware of Recommended Adult Vaccines
Less than 3 in 10 adults know they need vaccinations, which leads to low vaccination rates.
Five Strategies to Reduce Psychological Insulin Resistance
People with diabetes may have PIR, where they resist starting on insulin therapy, but pharmacists can use these strategies to help them.
Insulin Drug Prices Are on the Rise and States Want Answers
Several state attorneys general are asking pointed questions about why insulin prices are rising.

Poll